Abiopharma

Clinical trial NCT04089579: intervention model: CROSSOVER → PARALLEL.

Clinical trial NCT03651076: enrollment: 141 → 142 participants.

Clinical trial NCT06283966: enrollment: 5000 → 5250 participants.

Clinical trial NCT04954859 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2029-02-08 → 2029-01-24 3. primary completion date: 2029-02-08 → 2029-01-24 4. enrollment: 450 → 360 participants

Clinical trial NCT06129864 updates: 1. completion date: 2030-09-12 → 2031-02-28 2. primary completion date: 2028-04-18 → 2030-04-17

Clinical trial NCT07571200 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-14

Clinical trial NCT04205812 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-28 → 2026-05-28

Clinical trial NCT05272150: enrollment: 213 → 211 participants.

Clinical trial NCT06952010 updates: 1. enrollment: 75 → 303 participants 2. allocation: NA → NON_RANDOMIZED

Clinical trial NCT06892548 updates: 1. completion date: 2031-06-01 → 2032-05-01 2. primary completion date: 2027-08-01 → 2028-09-01